Ignite Creation Date:
2025-12-24 @ 11:24 PM
Ignite Modification Date:
2025-12-25 @ 9:10 PM
Study NCT ID:
NCT05144256
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-11-28
First Post:
2021-11-22
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Study to Evaluate the Efficacy and Safety of Mitapivat in Pediatric Participants With Pyruvate Kinase Deficiency (PKD) Who Are Regularly Transfused, Followed by a 5-Year Extension Period
Sponsor:
Agios Pharmaceuticals, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-06-08
Start Date Type:
ACTUAL
Primary Completion Date:
2024-05-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2029-06
Completion Date Type:
ESTIMATED
First Submit Date:
2021-11-22
First Submit QC Date:
None
Study First Post Date:
2021-12-03
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2024-12-18
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2025-11-26
Last Update Post Date:
2025-11-28
Last Update Post Date Type:
ESTIMATED